THREE INTERNATIONAL TOWERS LEVEL 24,, SYDNEY NSW, C3
Announces Doses First Patient in Phase 1b/2a Trial of Paxalisib for Rare Seizure Disorders
Appoints JPMorgan Chase Bank as Sole Depositary for ADR Program
Expands Paxalisib Clinical Trial into HR+/HER2- Breast Cancer, Supported by Preclinical Data Showing Strong Clinical Activity and Safety in HR+ Breast Cancer
Launches New Website
Announces Underwritten Public Offering of American Depositary Shares
Files Prospectus Supplement Reducing Maximum Offering Price
Reports 100% Clinical Benefit Rate in Initial Six Patients Treated for Advanced Triple-Negative Breast Cancer
Material disclosure
Annual and Transition Report of Foreign Private Issuers
Prospectus filed pursuant to Rule 424(b)(3)
No filings found
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
NT 20-F